| Publication |
Data |
|
Phenotype
|
|
Chen et al., 2019
|
Fig. 1
|
|
|
|
|
Fig. 2
|
|
|
|
|
Fig. 3
|
|
- liver L-methionine metabolic process increased occurrence, abnormal
- liver mannose metabolic process increased occurrence, abnormal
- liver nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway increased occurrence, abnormal
- liver proteasome assembly increased occurrence, abnormal
- liver purine nucleotide metabolic process increased occurrence, abnormal
- liver pyrimidine nucleobase metabolic process increased occurrence, abnormal
- liver regulation of amino acid biosynthetic process increased occurrence, abnormal
- liver regulation of phagosome maturation increased occurrence, abnormal
- liver ribosome biogenesis increased occurrence, abnormal
- liver RNA catabolic process increased occurrence, abnormal
- liver RNA polymerase I assembly increased occurrence, abnormal
- liver RNA transport increased occurrence, abnormal
- liver steroid biosynthetic process increased occurrence, abnormal
- liver terpenoid biosynthetic process increased occurrence, abnormal
|
|
|
Fig. 5
|
|
|